Girish Mahajan (Editor)

Romosozumab

Updated on
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Type  Whole antibody
Target  Sclerostin
Legal status  Investigational
Source  Humanized (from mouse)
ATC code  none
CAS Number  909395-70-6

Romosozumab (AMG 785) is a humanized monoclonal antibody that targets sclerostin for the treatment of osteoporosis.

Romosozumab was originally discovered by Celltech (now owned by UCB). Celltech entered in a partnership with Amgen in 2002 for the product's development.

References

Romosozumab Wikipedia


Similar Topics
The Rite (2011 film)
Jon Reinertsen
Esteban Carvajal
Topics
 
B
i
Link
H2
L